- Investing Ideas
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
4
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
4 companies
Strides Pharma Science
Market Cap: ₹96.0b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹1,041.70
7D
-0.9%
1Y
9.1%
Senores Pharmaceuticals
Market Cap: ₹61.0b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹1,323.90
7D
-5.7%
1Y
88.1%
Viyash Scientific
Market Cap: ₹110.5b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹253.25
7D
-4.4%
1Y
43.0%
Indoco Remedies
Market Cap: ₹21.0b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹228.05
7D
-7.2%
1Y
-28.6%